Event-Driven Stocks

Virpax Pharmaceuticals, Inc.

VRPX

Other · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 1 good● 3 warning● 3 severedetails ↓

Financials

SEC XBRL · annual
 FY24FY23FY22FY21FY20
Revenue—————
Operating income−$12.1M−$15.7M−$21.8M−$12.0M−$4.2M
Net income−$12.1M−$15.2M−$21.7M−$12.1M−$4.3M
Total assets$1.6M$9.6M$19.7M$39.6M$465,406
Total liabilities$2.5M$7.7M$3.1M$2.1M$4.7M
Equity−$913,760$1.9M$16.6M$37.5M−$4.2M
EPS (diluted)$-2.84$-12.97$-18.49$-1.81$-1.40
Shares out.1.2M11.7M11.7M11.7M3.1M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2024
Operating margin
—
Net margin
—
Return on equity
1320.6%
Return on assets
−775.7%
Return on capital (ROCE)
—
Liabilities / assets
158.7%
Debt / equity
—
Book value / share
$-0.78
Revenue growth (YoY)
—
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2024
Altman Z″ (distress)
-206.50distress
Accruals / assets
298.6%high accruals
Piotroski F-Score
1/7weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
21
/ 100
Profitability 50Growth n/aCatalyst 33Earnings quality 0Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

● 3 severe● 3 warning● 1 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • High accruals — earnings-quality risk
  • Strong return on equity (>15%)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202611,91633.90.0%
Apr 30, 202611,9165.90.0%
Apr 15, 202611,9165.20.0%
Mar 31, 202611,91625.50.0%
Mar 13, 202611,91670.90.0%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.